Amedica Corporation to Review Third Quarter 2017 Financial Results and Host Conference Call
November 15 2017 - 9:00AM
Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial
company that develops and manufactures silicon nitride as a
platform for biomedical applications, announced today that on
November 21, 2017, the company will host a conference call and
audio webcast with Dr. Sonny Bal, CEO of Amedica Corporation, to
review its third quarter 2017 financial results.
Details related to this call are as follows:
Date: November 21,
2017
Time: 9 AM MST
Conference ID:
13673764
Dial-in: Toll free 877 524
8416
International - +1-412-902-1028
Webcast: Investor section of
the company’s website
For those who are not available to listen to the
live webcast, a digital replay will be archived on the investor
relations section of the Amedica website under Events &
Presentations.
About Amedica Corporation
Amedica is focused on the development and
application of spinal interbody implants made with medical-grade
silicon nitride ceramic. Amedica markets spinal fusion products and
is developing implants for other biomedical applications, such as
wear- and corrosion-resistant hip and knee bearings, and dental
implants. The Company’s products are manufactured in its ISO 13485
certified manufacturing facility, and it has a partnership with
Kyocera, one of the world’s largest ceramic manufacturers.
Amedica’s FDA-cleared and CE-marked spine products are currently
marketed in the U.S. and select markets in Europe and South America
through its distributor network, and OEM and private label
partnerships.
For more information on Amedica
or its silicon nitride material platform, please visit
www.amedica.com.
Forward-Looking Statements
This press release contains statements that
constitute forward-looking statements within the meaning of the
Securities Act of 1933 and the Securities Exchange Act of 1934, as
amended by the Private Securities Litigation Reform Act of 1995.
Such statements are subject to risks and uncertainties that could
cause actual results to differ materially from those contemplated
within this press release. A discussion of those risks and
uncertainties can be found in Amedica’s Risk Factors disclosure in
its Annual Report on Form 10-K, filed with the Securities and
Exchange Commission (SEC) on September 20, 2017, and in Amedica’s
other filings with the SEC. Amedica disclaims any obligation to
update any forward-looking statements.
Contacts:
Amedica IR
801-839-3502
IR@amedica.com
AMEDICA CORP (NASDAQ:AMDA)
Historical Stock Chart
From Aug 2024 to Sep 2024
AMEDICA CORP (NASDAQ:AMDA)
Historical Stock Chart
From Sep 2023 to Sep 2024